Central Indiana Chapter of AACN

Attn: Upcoming National Virtual Speaker Program - Terlivaz (terlipressin IV for Hepatorenal syndrome) - November 20

Posted 12 days ago by Melissa Coxey

This announcement has 1 attachment:

Our friends from Mallinckrodt Pharmaceuticals have invited us to their upcoming National Virtual Speaker Program - Terlivaz (terlipressin IV for Hepatorenal syndrome) - November 20th. 
If anyone is interested in hearing more about Terlivaz -(terlipressin IV for Hepatorenal syndrome), we are hosting a virtual speaker presentation on November 20th at 3 PM EST. Login from anywhere to join. You can RSVP to the program via the link on the attached invite. The speaker will be David Quan, PharmD, Pharmacist Specialist - Solid Organ Transplantation, University of California San Francisco Medical Center, Health Sciences Clinical Professor of Pharmacy-University of California San Francisco San Francisco, CA. He will deliver a 25-30 minute slide deck followed by Q&A. 

PLEASE RSVP TO:
Your Local Mallinckrodt Pharmaceuticals Representative
OR
https://www.mymallinckrodtmeetings.com/4oJBEB

For more info please contact:

dan.diekhoff@mnk.com